Literature DB >> 25179501

Decade in review-bladder cancer: international progress: from cytology to genomics.

James C Costello1, Dan Theodorescu2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25179501     DOI： 10.1038/nrurol.2014.236

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Identifying distinct classes of bladder carcinoma using microarrays.

Authors:  Lars Dyrskjøt; Thomas Thykjaer; Mogens Kruhøffer; Jens Ledet Jensen; Niels Marcussen; Stephen Hamilton-Dutoit; Hans Wolf; Torben F Orntoft
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

2.  Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder.

Authors:  W-D Beecken; M Wolfram; T Engl; W Bentas; M Probst; R Blaheta; A Oertl; D Jonas; J Binder
Journal:  Eur Urol       Date:  2003-09       Impact factor: 20.096

3.  Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.

Authors:  Guangwu Guo; Xiaojuan Sun; Chao Chen; Song Wu; Peide Huang; Zesong Li; Michael Dean; Yi Huang; Wenlong Jia; Quan Zhou; Aifa Tang; Zuoquan Yang; Xianxin Li; Pengfei Song; Xiaokun Zhao; Rui Ye; Shiqiang Zhang; Zhao Lin; Mingfu Qi; Shengqing Wan; Liangfu Xie; Fan Fan; Michael L Nickerson; Xiangjun Zou; Xueda Hu; Li Xing; Zhaojie Lv; Hongbin Mei; Shengjie Gao; Chaozhao Liang; Zhibo Gao; Jingxiao Lu; Yuan Yu; Chunxiao Liu; Lin Li; Xiaodong Fang; Zhimao Jiang; Jie Yang; Cailing Li; Xin Zhao; Jing Chen; Fang Zhang; Yongqi Lai; Zheguang Lin; Fangjian Zhou; Hao Chen; Hsiao Chang Chan; Shirley Tsang; Dan Theodorescu; Yingrui Li; Xiuqing Zhang; Jian Wang; Huanming Yang; Yaoting Gui; Jun Wang; Zhiming Cai
Journal:  Nat Genet       Date:  2013-10-13       Impact factor: 38.330

4.  Promotion of bladder cancer development and progression by androgen receptor signals.

Authors:  Hiroshi Miyamoto; Zhiming Yang; Yei-Tsung Chen; Hitoshi Ishiguro; Hiroji Uemura; Yoshinobu Kubota; Yoji Nagashima; Yu-Jia Chang; Yueh-Chiang Hu; Meng-Yin Tsai; Shuyuan Yeh; Edward M Messing; Chawnshang Chang
Journal:  J Natl Cancer Inst       Date:  2007-04-04       Impact factor: 13.506

5.  Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

Authors:  Bernard H Bochner; Michael W Kattan; Kinjal C Vora
Journal:  J Clin Oncol       Date:  2006-07-24       Impact factor: 44.544

6.  Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.

Authors:  Hans von der Maase; Lisa Sengelov; James T Roberts; Sergio Ricci; Luigi Dogliotti; T Oliver; Malcolm J Moore; Annamaria Zimmermann; Michael Arning
Journal:  J Clin Oncol       Date:  2005-07-20       Impact factor: 44.544

7.  Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.

Authors:  Bas W G van Rhijn; Irene Lurkin; Dominique K Chopin; Wim J Kirkels; Jean-Paul Thiery; Theo H van der Kwast; François Radvanyi; Ellen C Zwarthoff
Journal:  Clin Cancer Res       Date:  2003-01       Impact factor: 12.531

8.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Authors:  Patrick J Killela; Zachary J Reitman; Yuchen Jiao; Chetan Bettegowda; Nishant Agrawal; Luis A Diaz; Allan H Friedman; Henry Friedman; Gary L Gallia; Beppino C Giovanella; Arthur P Grollman; Tong-Chuan He; Yiping He; Ralph H Hruban; George I Jallo; Nils Mandahl; Alan K Meeker; Fredrik Mertens; George J Netto; B Ahmed Rasheed; Gregory J Riggins; Thomas A Rosenquist; Mark Schiffman; Ie-Ming Shih; Dan Theodorescu; Michael S Torbenson; Victor E Velculescu; Tian-Li Wang; Nicolas Wentzensen; Laura D Wood; Ming Zhang; Roger E McLendon; Darell D Bigner; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

9.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

10.  A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery.

Authors:  Jae K Lee; Dmytro M Havaleshko; Hyungjun Cho; John N Weinstein; Eric P Kaldjian; John Karpovich; Andrew Grimshaw; Dan Theodorescu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-31       Impact factor: 11.205
  10 in total
  5 in total

1.  Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.

Authors:  Qianxing Mo; Fotis Nikolos; Fengju Chen; Zoe Tramel; Yu-Cheng Lee; Kazukuni Hayashi; Jing Xiao; Jianjun Shen; Keith Syson Chan
Journal:  J Natl Cancer Inst       Date:  2018-05-01       Impact factor: 13.506

2.  Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy.

Authors:  Qianxing Mo; Roger Li; Dennis O Adeegbe; Guang Peng; Keith Syson Chan
Journal:  Commun Biol       Date:  2020-12-17

3.  Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study.

Authors:  Evan Yi-Wen Yu; Hao Zhang; Yuanqing Fu; Ya-Ting Chen; Qiu-Yi Tang; Yu-Xiang Liu; Yan-Xi Zhang; Shi-Zhi Wang; Anke Wesselius; Wen-Chao Li; Maurice P Zeegers; Bin Xu
Journal:  Curr Oncol       Date:  2022-07-31       Impact factor: 3.109

4.  Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial-mesenchymal transition.

Authors:  Da-Jin Chen; Wei Chen; Hong Jiang; Hao Yang; Yu-Cheng Wang; Jiang-Hua Chen
Journal:  Drug Des Devel Ther       Date:  2016-09-08       Impact factor: 4.162

5.  Depletion of CDC5L inhibits bladder cancer tumorigenesis.

Authors:  Ziwei Zhang; Weipu Mao; Longsheng Wang; Mengnan Liu; Wentao Zhang; Yuan Wu; Junfeng Zhang; Shiyu Mao; Jiang Geng; Xudong Yao
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.478
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.